Faulkner Paul, Ghahremani Dara G, Tyndale Rachel F, Cox Chelsea M, Kazanjian Ari S, Paterson Neil, Lotfipour Shahrdad, Hellemann Gerhard S, Petersen Nicole, Vigil Celia, London Edythe D
Department of Psychiatry and Biobehavioral Sciences, Semel Institute, University of California, Los Angeles, CA, USA.
Department of Pharmacology &Toxicology, Campbell Family Mental Health Research Institute, Centre for Addiction &Mental Health (CAMH), University of Toronto, 1 King's College Circle, Toronto, ON, Canada.
Neuropsychopharmacology. 2017 Jul;42(8):1610-1618. doi: 10.1038/npp.2017.18. Epub 2017 Jan 24.
The use of cigarettes delivering different nicotine doses allows evaluation of the contribution of nicotine to the smoking experience. We compared responses of 46 young adult smokers to research cigarettes, delivering 0.027, 0.110, 0.231, or 0.763 mg nicotine, and conventional cigarettes. On five separate days, craving, withdrawal, affect, and sustained attention were measured after overnight abstinence and again after smoking. Participants also rated each cigarette, and the nicotine metabolite ratio (NMR) was used to identify participants as normal or slow metabolizers. All cigarettes equally alleviated craving, withdrawal, and negative affect in the whole sample, but normal metabolizers reported greater reductions of craving and withdrawal than slow metabolizers, with dose-dependent effects. Only conventional cigarettes and, to a lesser degree, 0.763-mg nicotine research cigarettes increased sustained attention. Finally, there were no differences between ratings of lower-dose cigarettes, but the 0.763-mg cigarettes and (even more so) conventional cigarettes were rated more favorably than lower-dose cigarettes. The findings indicate that smoking-induced relief of craving and withdrawal reflects primarily non-nicotine effects in slow metabolizers, but depends on nicotine dose in normal metabolizers. By contrast, relief of withdrawal-related attentional deficits and cigarette ratings depend on nicotine dose regardless of metabolizer status. These findings have bearing on the use of reduced-nicotine cigarettes to facilitate smoking cessation and on policy regarding regulation of nicotine content in cigarettes. They suggest that normal and slow nicotine metabolizers would respond differently to nicotine reduction in cigarettes, but that irrespective of metabolizer status, reductions to <0.763 mg/cigarette may contribute to temporary attentional deficits.
使用提供不同尼古丁剂量的香烟可以评估尼古丁对吸烟体验的影响。我们比较了46名年轻成年吸烟者对分别提供0.027、0.110、0.231或0.763毫克尼古丁的研究用香烟以及传统香烟的反应。在五个不同的日子里,在过夜戒烟后以及吸烟后再次测量渴望、戒断反应、情绪和持续注意力。参与者还对每支香烟进行评分,并使用尼古丁代谢物比率(NMR)来确定参与者是正常代谢者还是慢代谢者。所有香烟在整个样本中同等程度地减轻了渴望、戒断反应和负面影响,但正常代谢者报告的渴望和戒断反应减轻程度比慢代谢者更大,且具有剂量依赖性效应。只有传统香烟以及在较小程度上0.763毫克尼古丁的研究用香烟能提高持续注意力。最后,低剂量香烟的评分之间没有差异,但0.763毫克香烟以及(更明显的)传统香烟的评分比低剂量香烟更受欢迎。研究结果表明,吸烟引起的渴望和戒断反应缓解在慢代谢者中主要反映非尼古丁效应,但在正常代谢者中取决于尼古丁剂量。相比之下,与戒断相关的注意力缺陷的缓解和香烟评分取决于尼古丁剂量,而与代谢者状态无关。这些发现与使用低尼古丁香烟促进戒烟以及香烟尼古丁含量监管政策有关。它们表明正常和慢尼古丁代谢者对香烟中尼古丁减少的反应会有所不同,但无论代谢者状态如何,将尼古丁含量降低至<0.763毫克/支可能会导致暂时的注意力缺陷。